Last reviewed · How we verify
NCT05734781
End-of-life Communication From a Chinese Perspective
trial testing Not Application as this is a qualitative study in Terminally Ill in 66 participants. Completed in 31 October 2023.
31 October 2023
Quick facts
| Lead sponsor | The Hong Kong Polytechnic University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 66 |
| Start date | 4 May 2023 |
| Primary completion | 31 October 2023 |
| Estimated completion | 31 October 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Not Application as this is a qualitative study
Conditions studied
- Terminally Ill — all drugs for Terminally Ill →
Sponsor
The Hong Kong Polytechnic University
Who can join
18 and older, any sex, with Terminally Ill. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to explore experiences and perceptions of end-of-life communication in Chinese terminally ill patients, families and healthcare providers. The main question it aims to answer is: • What are the experiences and perceptions of end-of-life communication in Chinese terminally ill patients, families and healthcare providers? Participants will be invited to either semi-structured in-depth interviews or focus group discussions to share their thoughts.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Patients', families' and healthcare providers' perspectives on end-of-life communication in Chinese hospital settings: A qualitative study protocol.
Chen W, Chung JOK, Lam KKW, Molassiotis A. · · 2023 · cited 4× · PMID 38150444 · DOI 10.1371/journal.pone.0296342
Verify or expand the search:
- PubMed search for NCT05734781
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Not Application as this is a qualitative study
Trials testing the same drug.
- NCT05355779 — Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong · completed
Other The Hong Kong Polytechnic University trials
Trials by the same sponsor.
- NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
- NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
- NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
- NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
- NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05734781 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05734781.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing